Inventor

QUAN MIMI L

US67 patents

⚠️ This page may combine multiple inventors who share the name “QUAN MIMI L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

QUAN MIMI L

BRISTOL MYERS SQUIBB CO

Biarylmethyl indolines and indoles as antithromboembolic agents

Inhibitors of factor Xa with a neutral P1 specificity group

Dipeptide analogs as coagulation factor inhibitors

Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors

Substituted biaryl compounds as factor XIa inhibitors

Five-membered heterocycles useful as serine protease inhibitors

Tetrahydroquinoline derivatives useful as serine protease inhibitors

Heteroaryl-phenyl substituted factor Xa inhibitors

Macrocycles as factor XIa inhibitors

Macrocycles as factor XIa inhibitors

Substituted amino methyl factor Xa inhibitors

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

Substituted biaryl compounds as factor XIa inhibitors

N-[4-(1H-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as factor Xa inhibitors

Macrocycles as factor XIA inhibitors

Guanidine mimics as factor Xa inhibitors

GSPT1 compounds and methods of use of the novel compounds

Macrocycles as factor xia inhibitors

Macrocycles as factor XIa inhibitors

Substituted phthalazinones as rock inhibitors

Macrocycles as factor XIa inhibitors

Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors

Tetrahydroquinoline derivatives useful as serine protease inhibitors

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

Guanidine mimics as factor Xa inhibitors

Nitrogen containing heterobicycles as factor Xa inhibitors

Heteroaryl-phenyl heterobicyclic factor Xa inhibitors

Nitrogen containing heterobicycles as factor Xa inhibitors

Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa

Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors

Guanidine mimics factor Xa inhibitors

Intermediates for guanidine mimics as factor Xa inhibitors

Nitrogen containing heterobicycles as factor Xa inhibitors

Bicyclic inhibitors of factor Xa

DU PONT PHARM CO

Guanidine mimics as factor Xa inhibitors

Inhibitors of factor Xa with a neutral P1 specificity group

Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa

DU PONT

Angiotensin II receptor blocking imidazolinone derivatives

Angiotensin II receptor blocking imidazolinone derivatives

CORTE JAMES R

Macrocycles as factor XIa inhibitors

Pyridazine derivatives as factor xia inhibitors

DU PONT MERCK PHARMA

Imidazole 5-position substituted angiotensin II antagonists

Imidazole 5-position substituted angiotensin II antagonists

HANGELAND JON J

Five-membered heterocycles useful as serine protease inhibitors

Five-membered heterocycles useful as serine protease inhibitors

(unassigned)

Inhibitors of factor Xa with a neutral P1 specificity group

BRISTOL MEYERS SQUIBB PHARMA C

Nitrogen containing heterobicycles as factor Xa inhibitors

QUAN MIMI L

Macrocycles as factor XIa inhibitors